“Can’t they just diet and exercise?” That’s a question raised by some medical professionals. However, losing weight isn’t as simple as counting calories and doing grueling exercise routines. Ask anyone who has tried every diet and exercise fad only to regain the pounds. For Czarina Enriquez, there’s a better way to achieve results. The nurse practitioner is the founder of the California-based The A-List Clinic, which takes a different approach to traditional weight loss methods.
Many clinics still push a one-size-fits-all mentality. They overlook the complex factors that influence weight. For instance, stress, hormonal changes, genetics, and environmental factors are all pieces of a larger puzzle that diet and exercise alone cannot solve.
There’s medication available that benefits some patients. Two common options include Semaglutide and Tirzepatide. These prescriptions can cost upwards of $1,500 per month without insurance. “That price is infeasible for a lot of people, especially those who need it,” Enriquez says.
Additionally, some individuals don’t have supportive, long-term guidance. If you’re on a solo weight-loss mission, you may feel a sense of isolation.
These challenges point to an urgent need for accessible, empathetic care that empowers patients to succeed in the long run. And this is where The A-List Clinic is making its mark with affordable Semaglutide in California.
Enriquez knew the industry needed a change. “Obesity is a chronic disease and should be treated like any other,” she says. Instead, her clinic focuses on whole-body health and realistic, science-based solutions.
Enriquez has over a decade of nursing experience across diverse fields ranging from hospice to urgent care. One thing she noticed is overweight patients also suffered from comorbidities such as diabetes, hypertension, and hyperlipidemia. After witnessing the ripple effects of obesity, she was inspired to create The A-List Clinic.
The facility offers a combination of affordability, transparency, and an understanding of the human factors often ignored in weight loss programs. For example, Enriquez believes finances shouldn’t be a barrier to obtaining effective medication.
The A-List Clinic has partnered with compounding pharmacies. This collaboration allows them to offer affordable versions of weight loss medications like Semaglutide and Tirzepatide using the same active ingredients.
Enriquez also takes a hands-on approach when treating patients. “I want my clients to be able to talk to a real person,” she explains. She conducts regular monthly follow-ups. As a result, her patients receive tailored guidance, addressing medication-related concerns and adjusting programs as needed.
Despite increasing awareness about obesity, a stigma remains. Enriquez has set out to combat the myths. She shares reliable information and practical tools through her podcast, “The Weigh-In,” and social media platforms. To further expand these educational efforts, The A-List Clinic has partnered with Just Get Known, a New Jersey-based marketing firm specializing in online visibility and brand awareness. This collaboration enhances The A-List Clinic’s ability to reach a wider audience with its compassionate, science-driven guidance, making accurate weight loss information more accessible to those who need it most. These efforts have made the clinic a haven for those seeking compassionate, results-driven support.
The A-List Clinic, based in West Los Angeles (LA), may expand to additional states. Additionally, Enriquez is broadening the range of services to include testosterone therapy. Hormonal challenges like testosterone loss contribute to weight gain in men and women. These changes are most notable for women going through perimenopause or menopause.
The A-List Clinic is challenging industry norms regarding medical weight loss. Rather than dwelling on numbers on the scale, Czarina Enriquez prefers to take a holistic approach that empowers patients with the tools, knowledge, and support they deserve. Curious to learn more? Follow the clinic on Instagram and TikTok.
DISCLAIMER: No part of this article was written by The Signal editorial staff.
